The Joint Learning Network is gaining momentum in its next phase, focusing on the four technical tracks for JLN members— provider payment mechanisms (PPM), quality, information technology (IT), and expanding coverage.
R4D released a new report “Prizes for Global Health Technologies” at a briefing convened by the White House Office of Science and Technology Policy (OSTP) on March 29 that educated leaders from federal agencies on how to use prizes to spur innovation.
R4D released a new report “Prizes for Global Health Technologies” at a briefing convened by the White House Office of Science and Technology Policy (OSTP) on March 29 that educated leaders from federal agencies on how to use prizes to spur innovation. The R4D experts who authored the report are Paul Wilson, R4D Senior Consultant and Amrita Palriwala, R4D Program Officer.
The Center for Global Health R&D Policy Assessment’s report “Prizes for Global Health Technologies” addresses how prizes may be used to spur medical innovation for neglected diseases and drive investment in the development of drugs, vaccines, and diagnostics needed in poor countries.
Prizes have stimulated breakthroughs in areas as diverse as mathematics, agriculture, and space flight. But can prizes also spur medical innovation for neglected diseases?
A new Results for Development Institute (R4D) report, Prizes for Global Health Technologies, was released at a White House Office of Science and Technology Policy (OSTP) briefing.
A new R4D report, "Prizes for Global Health Technologies," was released today at a White House Office of Science and Technology Policy (OSTP) briefing.
Recent success in the largest prize competition for medical research in history drew the attention of the New York Times which included comments by Results for Development Institute (R4D) senior consultant Dr. Paul Wilson.
Recent success in the largest prize competition for medical research in history drew the attention of the New York Times which included comments by Results for Development Institute (R4D) senior consultant Dr. Paul Wilson.
On December 9th R4D’s Center for Global Health R&D Policy Assessment, hosted a “Dialogue with Funders” to disseminate initial findings from a series of recently released draft assessments.
On October 20th, R4D’s Center for Global Health R&D Policy Assessment hosted a webinar and meeting to discuss the use of prizes to promote research and development for neglected diseases. The purpose of the session was to share preliminary results from R4D’s study, one of the first outputs from the Center, on incentive prizes and their potential to encourage private sector investment in new technologies (drugs, vaccines, and diagnostics) for the developing world.
Hundreds of millions of people are affected by “diseases of the poor”, such as African sleeping sickness, Leishmaniasis, and Chagas disease, as well as better known killers like Malaria and Tuberculosis. Yet there are far too few drugs, vaccines, and diagnostic tests to address these health challenges.
An initiative co-sponsored by the Results for Development Institute (R4D) and the Corporación Andina de Fomento (CAF) has won top honors at the Marketplace on Innovative Financial Solutions for Development, a competition hosted by the Agence Française de Développement (AFD), the Bill and Melinda Gates Foundation, and the World Bank.